Credit Suisse Ag Cor Medix Inc. Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.73 - $5.61 $2.05 Million - $4.22 Million	-752,693 Reduced 100.0%	20 $0
Q1 2022 May 16, 2022	SELL	$3.83 - $6.24 $8,127 - $13,241	-2,122 Reduced 0.28%	752,713 $4.13 Million
Q4 2021 Feb 14, 2022	BUY	$4.47 - $5.56 $19,650 - $24,441	4,396 Added 0.59%	754,835 $3.43 Million
Q3 2021 Nov 12, 2021	SELL	$4.46 - $7.11 $419 - $668	-94 Reduced 0.01%	750,439 $3.49 Million
Q2 2021 Aug 16, 2021	SELL	$6.05 - $10.09 $17,847 - $29,765	-2,950 Reduced 0.39%	750,533 $5.15 Million
Q1 2021 May 14, 2021	BUY	$6.84 - $17.58 $5.15 Million - $13.2 Million	753,483 New	753,483 $7.53 Million

109

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $502M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.